Back to results
US 2026/0263269 A1Published application
Schlemm's canal drug eluting device and method
AssigneeAlcon Inc.
InventorBrett A. TRAUTHEN
Life of this patent
Estimating the term…
Abstract
A method of delivering a pharmaceutical composition to Schlemm’s canal of an eye is disclosed. The method may comprise inserting a drug delivery device in conjunction with a microstent into Schlemm’s canal. The drug delivery device may comprise a bioerodable polymer and a pharmaceutical composition, and the drug delivery device may be configured to erode over time and to elute the pharmaceutical composition into aqueous humor within Schlemm’s canal as it erodes.
Claims13
A system for delivering a pharmaceutical composition to Schlemm’s canal, comprising:
- a microstent configured to be inserted in Schlemm’s canal, the microstent comprising an open central channel bordered in part by one or more wall supports;
- and
- a drug delivery device configured to be inserted into Schlemm’s canal, the drug delivery device comprising a bioerodable polymer and a pharmaceutical composition;
- wherein the drug delivery device is further configured to erode over time and to elute the pharmaceutical composition into aqueous humor within Schlemm’s canal as it erodes in order to dilate one or more of an outflow channel and an episcleral vein.
1 more element
Dependencies are inferred from the claim text.